Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance)

Author:

Lee Seohyuk1ORCID,Ma Chao2,Zhang Sui2,Ou Fang-Shu3ORCID,Bainter Tiffany M3,Niedzwiecki Donna4,Saltz Leonard B5,Mayer Robert J6,Whittom Renaud7,Hantel Alexander8,Benson Al9,Atienza Daniel10,Kindler Hedy11ORCID,Gross Cary P12,Irwin Melinda L13,Meyerhardt Jeffrey A6,Fuchs Charles S1415

Affiliation:

1. Yale School of Medicine , New Haven, CT , USA

2. Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, MA , USA

3. Alliance Statistics and Data Management Center, Mayo Clinic , Rochester, MN , USA

4. Department of Biostatistics and Bioinformatics, Duke University , Durham, NC , USA

5. Memorial Sloan Kettering Cancer Center , New York, NY , USA

6. Department of Medical Oncology, Dana-Farber/Partners CancerCare , Boston, MA , USA

7. Hôpital du Sacré-Coeur de Montréal , Montreal , Canada

8. Loyola University Stritch School of Medicine , Naperville, IL , USA

9. Robert H. Lurie Comprehensive Cancer Center, Northwestern University , Chicago, IL , USA

10. Virginia Oncology Associates , Norfolk, VA , USA

11. University of Chicago Comprehensive Cancer Center , Chicago, IL , USA

12. Yale School of Medicine, Department of Internal Medicine , New Haven, CT , USA

13. Yale School of Public Health, New Haven, CT , USA

14. Yale Cancer Center, Smilow Cancer Hospital and Yale School of Medicine , New Haven, CT , USA

15. Genentech , South San Francisco, CA , USA

Abstract

Abstract Background Limited and conflicting findings have been reported regarding the association between social support and colorectal cancer (CRC) outcomes. We sought to assess the influences of marital status and living arrangement on survival outcomes among patients with stage III colon cancer. Patients and Methods We conducted a secondary analysis of 1082 patients with stage III colon cancer prospectively followed in the CALGB 89803 randomized adjuvant chemotherapy trial. Marital status and living arrangement were both self-reported at the time of enrollment as, respectively, married, divorced, separated, widowed, or never-married, and living alone, with a spouse or partner, with other family, in a nursing home, or other. Results Over a median follow-up of 7.6 years, divorced/separated/widowed patients experienced worse outcomes relative to those married regarding disease free-survival (DFS) (hazards ratio (HR), 1.44 (95% CI, 1.14-1.81); P =.002), recurrence-free survival (RFS) (HR, 1.35 (95% CI, 1.05-1.73); P = .02), and overall survival (OS) (HR, 1.40 (95% CI, 1.08-1.82); P =.01); outcomes were not significantly different for never-married patients. Compared to patients living with a spouse/partner, those living with other family experienced a DFS of 1.47 (95% CI, 1.02-2.11; P = .04), RFS of 1.34 (95% CI, 0.91-1.98; P = .14), and OS of 1.50 (95% CI, 1.00-2.25; P =.05); patients living alone did not experience significantly different outcomes. Conclusion Among patients with stage III colon cancer who received uniform treatment and follow-up within a nationwide randomized clinical trial, being divorced/separated/widowed and living with other family were significantly associated with greater colon cancer mortality. Interventions enhancing social support services may be clinically relevant for this patient population. Trial Registration ClinicalTrials.gov Identifier: NCT00003835

Funder

National Cancer Institute

National Institutes of Health

Alliance for Clinical Trials in Oncology

Douglas Gray Woodruff Chair

Guo Shu Shi Fund

Anonymous Family Fund for Innovations in Colorectal Cancer

George Stone Family Foundation

Pharmacia & Upjohn Company

Stand-Up-to-Cancer Colorectal Cancer Dream Team

Entertainment Industry Foundation

American Association for Cancer Research

Scientific Partner of SU2C

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3